Rivaroxaban Shown to Cut Risk of Cardiovascular Events
Rivaroxaban (Xarelto, Janssen/ Bayer) has been found to significantly reduce the risk of strokes and heart attacks in patients with artery disease.
FDA Sends Warning Letter to EpiPen Manufacturer
EpiPen manufacturer is accused of lax investigation into problems.
Patient and Physician Education Boosts Anticoagulant Adherence Rates
Education about anticoagulants helped boost adherence rates and led to a small decrease in stroke risk.
FDA Recommends Separate Dosing for Kayexalate
Sodium polystyrene sulfonate interferes with many oral drugs and should be dosed separately.
Most U.S. Hospitals Use EHRs, CPOE Systems
The use of health IT has exploded in the last decade, and that means better health care.
FDA Warning on Keytruda
After trials halted, FDA issues warning on off-label use of the drug.
Leukemia Drug Approved-For the Second Time
After Mylotarg was taken voluntarily taken off the market, the FDA is giving it a second chance.
New York City Bans Pharmacy Tobacco Sales
The city's decision is the latest move against tobacco in pharmacies.
Two OTC Cold Medications Recalled Due to Bacterial Contamination
Mid Valley Pharmaceutical recalls two drugs.
Should the FDA Drop High-Dose Opioids?
A petition sent by multiple groups says yes.
Pharmacists Tackle Hurricane Harvey
In the midst of unprecedented disaster, pharmacists and pharmacies were prepared.
FDA Approves First Gene Therapy
Why the agency says the approval of Novartis’ new therapy is historic.
FDA Cracks Down on Regenerative and Stem Cell Therapies
New therapies hold great promise-and great danger.
Ninjacof Recall, Tied to Previous PharmaTech Recalls
The recall is just the latest in a bacterial contamination scare.
Top 7 Weirdest Pharmacy Robberies
Robberies are never a good thing, but sometimes they make for the craziest stories.
Pharmacy Owner Convicted in Opioids Case
An opioid scheme ends in prison and hefty fines.
Online Pharmacies: A Safety Concern?
Why the NABP says Canada isn't a safe alternative.
Pharmacists Increase Vaccination Rates
How pharmacists are helping to push vital health efforts.
Gottlieb Pushes for Generic Drug Access
Brand name drug companies are "gaming" the system, according to the FDA head.
Law Reauthorizes FDA Fees and Increases Access to Generics/Biosimilars
Senate passes FDARA overwhelmingly, ahead of September deadline.
New Bill Could Force E-prescribing
Legislators say it will help ease the problem, but the NCPA says it’s just one part of the solution.
Express Scripts Limits Opioid Prescriptions
The PBM giant is cutting down on the number of opioids new patients can buy.
Mylan Finalizes $465 Million EpiPen Settlement
The settlement is the end of a long legal battle.
Walgreens Launches Site for its Outcomes Research Studies
New Walgreens website will showcase the chain’s research on adherence and other topics.
Biosimilars Market Taking Off in the United States
After many years of speculation, a number of biosimilar drugs are hitting the U.S. market.
Inconsistent Labeling of Sulfites Could Cause Harm
A tricky labeling system could be affecting your patients.
Generics Savings Continue, but Work Remains
Generic drugs make up 90% of prescriptions.
Job Market Shifting for Pharmacy School Grads
Where are today's grads going (and why are there fewer of them)?
Retailers and PBMs Laud Generic/Biosimilar Savings
Savings from generic and biosimilar drugs are making PBMs and pharmacies, as well as patients, happy.
Biosimilars Have Entered the Market, But Are They Safe?
Biosimilars are starting to come on the market, but some have questions about their safety.
